Drug intelligence / Profile preview

PER2 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral, Intraperitoneal, Intrathecal, Subcutaneous
01

Overview

PER2 siRNA is a small interfering RNA (siRNA) designed to silence the expression of the Period circadian protein 2 (PER2) gene. PER2 is a core component of the mammalian circadian clock and plays a significant role in regulating inflammatory responses. Research indicates that PER2 can promote inflammation by upregulating pro-inflammatory cytokines such as TNF-α and IL-6 and suppressing the anti-inflammatory activity of BMAL1. In preclinical studies, PER2 siRNA is used to knockdown PER2 expression in cell lines (such as RAW 264.7 macrophages) and animal models to investigate its role in chronic inflammatory skin disorders like atopic dermatitis. Silencing PER2 has been shown to reduce the production of inflammatory cytokines and nitric oxide, suggesting that targeting the circadian clock components may offer a therapeutic pathway for managing allergic and inflammatory diseases.

Other names
Per2 siRNAPer-2 siRNAPer 2 siRNAPeriod circadian protein 2 siRNA
02

Targets

IFIH1 (MDA5)TLR7 (Toll-like receptor 7)EIF2AK2 (Interferon-induced protein kinase R)TLR8 (Toll-like receptor 8)Period circadian protein homolog 2 (PER2) mRNA

Beyond the preview

Go deeper on PER2 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PER2 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call